Literature DB >> 1763183

Antifungal chemotherapy--are we winning?

A Polak1, P G Hartman.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1763183     DOI： 10.1007/978-3-0348-7139-6_5

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN： 0071-786X


× No keyword cloud information.
  3 in total

1.  Rapid susceptibility testing of Candida albicans by flow cytometry.

Authors:  S M Kirk; S M Callister; L C Lim; R F Schell
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

2.  In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE.

Authors:  T Woyke; G R Pettit; G Winkelmann; R K Pettit
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Inhibition of sterol 4-demethylation in Candida albicans by 6-amino-2-n-pentylthiobenzothiazole, a novel mechanism of action for an antifungal agent.

Authors:  T Kuchta; C Léka; P Farkas; H Bujdáková; E Belajová; N J Russell
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.